Shiromardana - A novel Ayurveda add on therapy in the management of Opioid withdrawal insomnia- A case report.

2021 ◽  
Vol 10 (2) ◽  
pp. 177
Author(s):  
Subhash M ◽  
Suhas Shetty
F1000Research ◽  
2019 ◽  
Vol 8 ◽  
pp. 1073
Author(s):  
Mahmoud M. Ali ◽  
Abdelrahman Hamad ◽  
Eman Nawash Alhamoud

This case report describes a possible unknown complication of morphine withdrawal in a patient with persistent back pain, treated with intrathecal morphine pump infusion. The patient presented with left lower extremity edema. After excluding deep vein thrombosis by Doppler ultrasound and worsening of the swelling despite oral antibiotics, peripheral edema caused by intrathecal morphine was suspected.  Twelve hours following the termination of his intrathecal morphine pump and initiation of inequivalent doses of oral morphine and tramadol, he developed convulsions. After metabolic and structural causes of convulsion were ruled out by blood tests and head imaging, equivalent doses of morphine were given. Then the patient regained full consciousness, and no additional seizures occurred. After that, opioid withdrawal emerged as the most likely explanation. Seizure is a life-threating condition; therefore, an awareness of this case is important and further studies are warranted to explore the potential association of opioid withdrawal and seizure.


2016 ◽  
Vol 17 (4) ◽  
pp. S88 ◽  
Author(s):  
N. Sekhri ◽  
N. Knox

2020 ◽  
Vol 9 (2) ◽  
pp. 82-84
Author(s):  
B Regmi ◽  
S Limbu ◽  
S Nepal

Opioids are commonly used and abused substance worldwide. Opioid withdrawal may manifest as severe muscle cramps, diarrhea, rhinorrhea, lacrimation, piloerection, yawning, and fever. Here, we report a 32 year old man with heroin dependence, presented with new onset generalized tonic-clonic seizure following heroin withdrawal. Seizure is a life-threating condition and rare phenomenon in opioid withdrawal therefore, reporting of this case is important. It may help clinician to be aware and consider seizure as a part of opioid withdrawal.


2020 ◽  
Vol 21 ◽  
Author(s):  
Qingwu Kong ◽  
Martin Griffis ◽  
Brandon J. Shallop ◽  
Amrit S. Khalsa ◽  
Kyle Brougham ◽  
...  

2020 ◽  
Vol 185 (9-10) ◽  
pp. e1872-e1875
Author(s):  
Kathryn R Kinasz ◽  
Ellen D Herbst ◽  
Raj K Kalapatapu

Abstract Buprenorphine induction can lead to precipitated opioid withdrawal, even when using novel techniques such as transdermal buprenorphine. Involuntary limb movements are a distressing symptom of precipitated withdrawal that can be difficult to treat. We report a case of a military veteran transitioning from methadone to buprenorphine for the treatment of opioid use disorder (OUD) using small doses of transdermal buprenorphine. Herein, we review the literature associated with opioid withdrawal-related restlessness. Despite the known risk of concurrent benzodiazepine and buprenorphine administration, including decreased respiratory rate and death, we present a clinical presentation in which this medication combination may be necessary while under medical supervision. We suggest a stepwise algorithm for pharmacotherapy in patients experiencing involuntary limb movements associated with precipitated withdrawal. To safeguard the success of medication-assisted treatment (MAT) for opioid addiction, clinicians should be aware of potential clinical challenges when managing precipitated opioid withdrawal in patients with complex psychiatric comorbidities.


2016 ◽  
Vol 16 (1) ◽  
Author(s):  
Laurence Lalanne ◽  
Chloe Nicot ◽  
Jean-Philippe Lang ◽  
Gilles Bertschy ◽  
Eric Salvat

2010 ◽  
Vol 6 (4) ◽  
pp. 300-303 ◽  
Author(s):  
Xiulu Ruan, MD ◽  
Tao Chen, MD, PhD ◽  
Jeff Gudin, MD ◽  
John Patrick Couch, MD ◽  
Srinivas Chiravuri, MD

2021 ◽  
Vol 11 (3) ◽  
pp. 220-224
Author(s):  
Aimee N. Jensen ◽  
Quynh-Nhu Truong ◽  
Melanie Jameson ◽  
Celeste N. Nadal

Abstract Kratom is an herbal supplement that has gained popularity for recreational use within the United States. Kratom exerts opioid-like effects and, although not US FDA approved, is commonly used for self-treatment of pain, withdrawal management from opioids, and euphoria. Drug-related hepatic injury has been associated with kratom use. All of this raises concern for patient safety and monitoring. The potential for additive liver toxicity must be considered when kratom is used concurrently with hepatotoxic, over-the-counter, herbal, and prescription medications. This case report describes a case of kratom-induced liver inflammation complicated by opioid withdrawal that was precipitated by initiation of IM naltrexone. To our knowledge, there are no published case reports related to opioid withdrawal following naltrexone administration in patients using kratom (without other opioids). The purpose of this case report is to demonstrate potential complications that may arise with kratom use and considerations that should be taken prior to initiation of naltrexone in kratom users.


2020 ◽  
Vol 29 (4) ◽  
pp. 685-690
Author(s):  
C. S. Vanaja ◽  
Miriam Soni Abigail

Purpose Misophonia is a sound tolerance disorder condition in certain sounds that trigger intense emotional or physiological responses. While some persons may experience misophonia, a few patients suffer from misophonia. However, there is a dearth of literature on audiological assessment and management of persons with misophonia. The purpose of this report is to discuss the assessment of misophonia and highlight the management option that helped a patient with misophonia. Method A case study of a 26-year-old woman with the complaint of decreased tolerance to specific sounds affecting quality of life is reported. Audiological assessment differentiated misophonia from hyperacusis. Management included retraining counseling as well as desensitization and habituation therapy based on the principles described by P. J. Jastreboff and Jastreboff (2014). A misophonia questionnaire was administered at regular intervals to monitor the effectiveness of therapy. Results A detailed case history and audiological evaluations including pure-tone audiogram and Johnson Hyperacusis Index revealed the presence of misophonia. The patient benefitted from intervention, and the scores of the misophonia questionnaire indicated a decrease in the severity of the problem. Conclusions It is important to differentially diagnose misophonia and hyperacusis in persons with sound tolerance disorders. Retraining counseling as well as desensitization and habituation therapy can help patients who suffer from misophonia.


2011 ◽  
Vol 21 (1) ◽  
pp. 11-21 ◽  
Author(s):  
Farzan Irani ◽  
Rodney Gabel

This case report describes the positive outcome of a therapeutic intervention that integrated an intensive, residential component with follow-up telepractice for a 21 year old male who stutters. This therapy utilized an eclectic approach to intensive therapy in conjunction with a 12-month follow-up via video telepractice. The results indicated that the client benefited from the program as demonstrated by a reduction in percent stuttered syllables, a reduction in stuttering severity, and a change in attitudes and feelings related to stuttering and speaking.


Sign in / Sign up

Export Citation Format

Share Document